期刊文献+

常染色体隐性遗传多巴反应性肌张力障碍的临床特点及基因突变位点分析 被引量:3

Clinical characteristics and genetic analysis of patients with autosomal recessive dopa-responsive dystonia
原文传递
导出
摘要 目的分析常染色体隐性多巴反应性肌张力障碍(AR-DRD)的临床特点及基因突变情况,探讨其治疗效果、随访结果及分子遗传学机制。方法应用高通量测序技术对2016年4月至2017年9月首都儿科研究所附属儿童医院门诊收治的6例否认家族史的运动障碍疾病患儿进行全外显子基因检测,并采用Sanger测序技术进行家系验证分析突变来源。结果1.临床特点:6例患儿均为婴儿期起病,伴肌力下降、肌张力异常,其中以肌张力减低为著。2.基因突变:6例患儿均存在酪氨酸羟化酶(TH)基因突变,5例患儿为复合杂合突变,1例患儿为纯合突变,共检测到5种突变:c.605 G>A 、c.601 C>T、c.364C>T、c.1412_1413insCCCCCAGGCCGTGC和c.646G>A。3.治疗效果:6例患儿经多巴胺治疗后运动功能改善,表现为肌张力及肌力均有不同程度改善。结论携带c.605 G>A突变AR-DRD患儿对多巴胺治疗效果较好,该突变可能为国内外轻中度缺陷型AR-DRD常见变异位点。c.1412_1413insCCCCCAGGCCGTGC移码突变尚未被报道,为本研究新发现的TH基因致病性突变位点。 Objective To analyze the clinical characteristics and gene mutation of autosomal recessive dopa-responsive dystonia(AR-DRD), and to explore its therapeutic effect, follow-up findings and molecular genetic me-chanism. Methods The whole exome sequencing, which based on next-generation sequencing, was performed in 6 movement-disordered patients who denied family history at the outpatient clinic of Children′s Hospital Affiliated to Capital Institute of Pediatrics from April 2016 to September 2017.The mutations identified in probands were then confirmed in probands and their parents by Sanger sequencing in order to analyze the cause of mutations. Results (1)Clinical features: the onset of 6 patients was around infancy, complicated with muscle weakness and abnormal muscle tone.(2)Gene mutation analysis: All 6 patients carried TH gene mutations.Five patients were of complex heterozygosis mutations, 1 patient was of homozygosis mutation.Five mutations were detected: c.605 G>A, c.601 C>T, c.364C>T, c.1412_1413insCCCCCAGGCCGTGC and c. 646G>A.(3)Therapeutic effect: all 6 patients achieved improvement of motor function after dopamine treatment, and they presented the different degrees of improvement in muscle tone and muscle strength. Conclusions The AR-DRD patients who carried c. 605 G>A mutation have a good therapeutic effect treated with L-Dopamine.This mutation may be a common mutation site of mild to moderate defective AR-DRD at home and abroad.The frameshift mutation c. 1412_1413insCCCCCAGGCCGTGC is a new TH gene pathogenicity mutation site discovered by this study.
作者 王珺 王妍 陈汪洋 王立文 Wang Jun;Wang Yan;Chen Wangyang;Wang Liwen(Department of Neurology,Children′s Hospital Affiliated to Capital Institute of Pediatrics,Beijing 100020,China;Kaiumph Medical Diagnostics Co.,Ltd,Beijing 100102,China)
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2019年第10期759-762,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 北京市卫生系统高层次卫生技术人才培养计划(2015-3-084) 首都临床特色应用研究(Z131107002213159).
关键词 多巴反应性肌张力障碍 酪氨酸羟化酶基因 左旋多巴 高通量测序 Dopa-responsive dystonia Gene of tyrosine hydroxylase L-dopamine Next generation sequencing
  • 相关文献

参考文献3

二级参考文献5

  • 1谢卉,吴志英,王柠,李智文,林珉婷,慕容慎行.多巴反应性肌张力障碍临床分析及GCHⅠ基因突变的研究[J].中华儿科杂志,2006,44(7):492-495. 被引量:8
  • 2Segawa M, Ohmi K, Itoh S,et al. Childhood basal ganglia disease with remarkable response to L - Dopa, hereditary basal ganglia dis- easewith marked diurnal fluctuation [ J ]. Shinryo ( Tokyo), 1971, 24:667 - 672.
  • 3Nygaard TG, Marsden CD, Duvoisin RC. Dopa - responsive dystonia [ J]. Adu Neurol, 1988,50:377 - 384.
  • 4Nygaard TG, Marsden CD, Duvoisin RC. Dopa- responsive dysto- nia[ J]. Adu Neurol, 1988,50:377 - 384.
  • 5Liu X, Zhang SS, Fang DF, et al. GCH1 mutation and clinical study of Chinese patients with dopa - responsive dystonia [ J ]. Mov Dis- ord,2010,25(4) :447 -451.

共引文献7

同被引文献8

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部